Placebo to Remibrutinib (LOU064) 00 mg film-coated tablet, LOU064
CLOU064O12301
Phase 3 small_molecule active
Quick answer
Placebo to Remibrutinib (LOU064) 00 mg film-coated tablet, LOU064 for Generalized Myasthenia Gravis is a Phase 3 program (small_molecule) at Novartis Ophthalmics Europe with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Novartis Ophthalmics Europe
- Indication
- Generalized Myasthenia Gravis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active